project id: TCGA-ESCA; case submitter id: TCGA-VR-A8ER; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 7.9; age at index: 54; days to birth: -19951; days to death: 378; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1955; year of death: 2010; age at diagnosis: 19951; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage III; ajcc clinical t: T4; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.6712328767123288; pack years smoked: 12.25; is ffpe: false; composition: Not Reported; days to collection: 1475; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-VR-A8ER-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 0.0; percent necrosis: 8.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 52.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;